表紙
市場調査レポート

子宮頚部異形成:世界の治験動向

Cervical Dysplasia Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 224003
出版日 ページ情報 英文 89 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
子宮頚部異形成:世界の治験動向 Cervical Dysplasia Global Clinical Trials Review, H2, 2015
出版日: 2015年07月15日 ページ情報: 英文 89 Pages
概要

当レポートでは、子宮頚部異形成の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 子宮頚部異形成
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:婦人科疾患治療薬の治験における子宮頚部異形成の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:婦人科疾患治療薬の治験における子宮頚部異形成の割合

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

子宮頚部異形成治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • GenoLac BL Corporation
    • AnGes MG, Inc.
    • Merck Sharp & Dohme Corp. (Inactive)
    • Merck & Co., Inc.
    • Kirax Corporation
    • Inovio Pharmaceuticals, Inc.
    • CEL-SCI Corporation
    • Bioleaders Corporation
    • エーザイ
    • Akela Pharma Inc. (Inactive)
  • 代表的な研究機関・病院の治験の概要
    • Maastricht University Medical Center
    • Medical University of Vienna
    • The National Institute of Allergy and Infectious Diseases
    • 東京大学医学部附属病院
    • Center for Genetic Engineering and Biotechnology
    • Centre Hospitalier Regional Universitaire de Tours
    • Chiang Mai University
    • Christine Fromer-Stiftung
    • Dana-Farber Cancer Institute, Inc.
    • Department of Health, South Africa

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2769CTIDB

GlobalData's clinical trial report, "Cervical Dysplasia Global Clinical Trials Review, H2, 2015" provides an overview of Cervical Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cervical Dysplasia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cervical Dysplasia to Women's Health Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cervical Dysplasia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cervical Dysplasia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GenoLac BL Corporation
      • Clinical Trial Overview of GenoLac BL Corporation
      • AnGes MG, Inc.
      • Clinical Trial Overview of AnGes MG, Inc.
      • Merck Sharp & Dohme Corp. (Inactive)
      • Clinical Trial Overview of Merck Sharp & Dohme Corp. (Inactive)
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Kirax Corporation
      • Clinical Trial Overview of Kirax Corporation
      • Inovio Pharmaceuticals, Inc.
      • Clinical Trial Overview of Inovio Pharmaceuticals, Inc.
      • CEL-SCI Corporation
      • Clinical Trial Overview of CEL-SCI Corporation
      • Bioleaders Corporation
      • Clinical Trial Overview of Bioleaders Corporation
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Akela Pharma Inc. (Inactive)
      • Clinical Trial Overview of Akela Pharma Inc. (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • The University of Tokyo Hospital
      • Clinical Trial Overview of The University of Tokyo Hospital
      • Center for Genetic Engineering and Biotechnology
      • Clinical Trial Overview of Center for Genetic Engineering and Biotechnology
      • Centre Hospitalier Regional Universitaire de Tours
      • Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Tours
      • Chiang Mai University
      • Clinical Trial Overview of Chiang Mai University
      • Christine Fromer-Stiftung
      • Clinical Trial Overview of Christine Fromer-Stiftung
      • Dana-Farber Cancer Institute, Inc.
      • Clinical Trial Overview of Dana-Farber Cancer Institute, Inc.
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Cervical Dysplasia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Cervical Dysplasia Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GenoLac BL Corporation, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp & Dohme Corp. (Inactive), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirax Corporation, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Inovio Pharmaceuticals, Inc., 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by CEL-SCI Corporation, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioleaders Corporation, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Akela Pharma Inc. (Inactive), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Tours, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Christine Fromer-Stiftung, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015*

List of Figures

  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Cervical Dysplasia to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Cervical Dysplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Cervical Dysplasia to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Cervical Dysplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Cervical Dysplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top